1. Home
  2. PODC vs DXR Comparison

PODC vs DXR Comparison

Compare PODC & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PODC
  • DXR
  • Stock Information
  • Founded
  • PODC 2013
  • DXR 1970
  • Country
  • PODC United States
  • DXR United States
  • Employees
  • PODC N/A
  • DXR N/A
  • Industry
  • PODC
  • DXR Medical/Dental Instruments
  • Sector
  • PODC
  • DXR Health Care
  • Exchange
  • PODC Nasdaq
  • DXR Nasdaq
  • Market Cap
  • PODC 39.6M
  • DXR 46.9M
  • IPO Year
  • PODC N/A
  • DXR N/A
  • Fundamental
  • Price
  • PODC $1.81
  • DXR $11.42
  • Analyst Decision
  • PODC
  • DXR Strong Buy
  • Analyst Count
  • PODC 0
  • DXR 1
  • Target Price
  • PODC N/A
  • DXR $25.00
  • AVG Volume (30 Days)
  • PODC 85.1K
  • DXR 6.8K
  • Earning Date
  • PODC 11-06-2025
  • DXR 01-01-0001
  • Dividend Yield
  • PODC N/A
  • DXR N/A
  • EPS Growth
  • PODC N/A
  • DXR 3.46
  • EPS
  • PODC N/A
  • DXR 0.36
  • Revenue
  • PODC $53,954,000.00
  • DXR $66,306.00
  • Revenue This Year
  • PODC $17.91
  • DXR N/A
  • Revenue Next Year
  • PODC $14.41
  • DXR N/A
  • P/E Ratio
  • PODC N/A
  • DXR $31.70
  • Revenue Growth
  • PODC 17.74
  • DXR N/A
  • 52 Week Low
  • PODC $1.10
  • DXR $6.55
  • 52 Week High
  • PODC $2.94
  • DXR $11.70
  • Technical
  • Relative Strength Index (RSI)
  • PODC 54.80
  • DXR 56.80
  • Support Level
  • PODC $1.71
  • DXR $11.37
  • Resistance Level
  • PODC $1.95
  • DXR $11.70
  • Average True Range (ATR)
  • PODC 0.15
  • DXR 0.50
  • MACD
  • PODC 0.04
  • DXR -0.00
  • Stochastic Oscillator
  • PODC 74.07
  • DXR 83.53

About PODC PodcastOne Inc.

PodcastOne Inc is a podcast platform and publisher that makes its content available to audiences via all podcasting distribution platforms, including its website, its PodcastOne app, Apple Podcasts, Spotify, Amazon Music, and more.

About DXR Daxor Corporation

Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.

Share on Social Networks: